U.S. Specialty Stores Stock News

NasdaqGS:ISRG
NasdaqGS:ISRGMedical Equipment

Intuitive Surgical (ISRG) Q1 Net Margin Near 28% Tests High P/E Growth Narrative

Intuitive Surgical (ISRG) opened 2026 with Q1 revenue of US$2.8b and basic EPS of US$2.31, alongside trailing 12 month revenue of US$10.6b and basic EPS of US$8.36 that sit against reported trailing earnings growth of 20.3% year over year. The company has seen quarterly revenue move from US$2.25b in Q1 2025 to US$2.77b in Q1 2026, while quarterly basic EPS shifted from US$1.95 to US$2.31 over the same period. This sets up a story where investors are likely to focus on how a roughly 28.2% net...
NasdaqCM:OSW
NasdaqCM:OSWConsumer Services

Is It Too Late To Consider OneSpaWorld Holdings (OSW) After Its Strong Multi Year Run

Wondering if OneSpaWorld Holdings at around US$23.47 still offers value, or if the big gains are already behind it? This article breaks down what the current price really implies. The stock has seen a 2.5% decline over the last 7 days, a 2.2% gain over 30 days, and is up 13.7% year to date, with 39.4% over 1 year, 100.7% over 3 years, and 126.5% over 5 years, which can change how investors think about both upside and risk. Recent news coverage has focused on OneSpaWorld Holdings as an...
NYSE:BRO
NYSE:BROInsurance

A Look At Brown & Brown (BRO) Valuation After A 42% One Year Shareholder Return Decline

Brown & Brown (BRO) is on many investors’ radars after recent share price moves, with the stock down about 42% over the past year while reporting annual revenue of US$5.76b and net income of US$1.04b. See our latest analysis for Brown & Brown. The recent share price of US$67.55 sits against a 1 year total shareholder return decline of 42.22%. In contrast, the 5 year total shareholder return of 32.31% points to a much stronger longer term picture and fading near term momentum. If you are...
NasdaqGS:AMAT
NasdaqGS:AMATSemiconductor

Has Applied Materials (AMAT) Run Too Far After 171% One Year Surge?

Wondering whether Applied Materials at US$403.91 is priced for perfection or still has room based on fundamentals? This article walks through what the numbers are really saying about value. The stock has logged returns of 3.6% over 7 days, 8.0% over 30 days, 50.2% year to date and 171.4% over the past year, which naturally raises questions about how much of the story is already in the price. Alongside these returns, investors have been watching ongoing commentary around semiconductor capital...
NasdaqGS:UAL
NasdaqGS:UALAirlines

United Airlines Holdings (UAL) Q1 Revenue Yield Strengthens Bullish Premium Narrative

United Airlines Holdings (UAL) has kicked off Q1 2026 with total revenue of US$14.6b and basic EPS of US$2.14, alongside trailing twelve month revenue of US$60.5b and EPS of US$11.33 that frame the latest quarter within a much larger earnings run rate. Over the past year, total revenue has moved from US$59.1b to US$60.5b, while quarterly revenue has shifted from US$13.2b in Q1 2025 to US$14.6b. Basic EPS in the same first quarter periods moved from US$1.18 to US$2.14 as net income rose from...
NYSE:AES
NYSE:AESRenewable Energy

AES Finance Shakeup Puts Focus On Valuation And Capital Priorities

AES (NYSE:AES) has reshuffled its senior finance team, with several leadership changes at the corporate and business unit level. Sherry Kohan is moving to serve as Chief Financial Officer of AES's U.S. Utilities business. Aubrey Jarred has been appointed Vice President, Controller, and principal accounting officer of AES. Bernerd Da Santos is transitioning to Chairman of the AES Clean Energy Board and Senior Strategic Advisor. AES operates as a global power company, with exposure to U.S...
NYSE:ROL
NYSE:ROLCommercial Services

Rollins (ROL) Flat 13.8% Margins Test Bullish Efficiency Narratives Heading Into Earnings

Rollins (ROL) opened 2026 with Q1 revenue of US$906.4 million and basic EPS of US$0.22, alongside trailing twelve month revenue of about US$3.8 billion and EPS of US$1.10 that reflect its broader earnings run rate. Over the last year, the company has seen revenue move from US$3.4 billion in the trailing twelve months to Q1 2025 to US$3.8 billion by Q1 2026, with EPS over the same trailing window shifting from US$0.99 to US$1.10. This sets up a results season in which investors are watching...
NYSE:LNN
NYSE:LNNMachinery

Assessing Lindsay (LNN) After Recent Share Price Weakness And DCF Upside Potential

Wondering whether Lindsay at around US$110.53 is a bargain or a value trap? This article breaks down what the current price might be implying about the business. The share price has moved 3.9% over the last 7 days, after a 7.7% decline over 30 days and a 13.8% decline over the past year. These moves may have changed how the market is viewing its risk and reward profile. Recent coverage around Lindsay has focused on its role within the Machinery space and how investors are reassessing...
NasdaqGS:STX
NasdaqGS:STXTech

Seagate Expands Desk Side Storage To Tap AI And Gaming Demand

Seagate Technology Holdings (NasdaqGS:STX) has unveiled a major refresh of its consumer and professional storage portfolio. The launch adds new high capacity, AI ready solutions across the Seagate, FireCuda, and LaCie brands. New products include bus powered USB C desktop drives and Thunderbolt 5 RAID options aimed at creators and gamers. For Seagate, best known for hard drives used in enterprise and data center environments, this refresh pushes further into storage gear designed for use...
NYSE:OSCR
NYSE:OSCRInsurance

Oscar Health Names New Chair As Investors Weigh Governance And Growth Focus

Oscar Health (NYSE:OSCR) has appointed Siddhartha Sankaran as Chair of the Board. Sankaran succeeds Jeffery Boyd, who served as Chair for five years. The leadership transition places an experienced insurance executive at the head of Oscar Health’s board. Oscar Health operates as a technology driven health insurer, focusing on individual and small group plans as well as related services. Board level decisions can shape how the company allocates resources between its core health plans and...
NYSE:CNK
NYSE:CNKEntertainment

Is It Time To Reassess Cinemark Holdings (CNK) After Recent Share Price Swings?

If you are wondering whether Cinemark Holdings at around US$28.53 is still reasonably priced after its recent run, this breakdown will help you frame that question clearly. The stock has had mixed returns, with a 4.6% decline over the last 7 days, a 2.6% gain over 30 days, 21.2% year to date, and a 0.5% decline over 1 year, which can leave investors unsure whether the current level reflects opportunity or higher risk. Recent headlines around cinema attendance trends, competition in the movie...
NYSE:FCF
NYSE:FCFBanks

Is It Too Late To Consider First Commonwealth Financial (FCF) After A 27.1% One-Year Gain?

Investors may be asking whether First Commonwealth Financial at around US$18.50 per share still offers value, or if the best of the opportunity is already on the table. The stock shows mixed recent returns, with a 1% decline over the last week, an 8.1% gain over the past month, and longer term returns of 10.3% year to date and 27.1% over the last year. Recent coverage has focused on First Commonwealth Financial as a regional bank stock that continues to attract attention in a sector many...
NYSE:MMM
NYSE:MMMIndustrials

Is It Time To Reconsider 3M (MMM) After Recent Share Price Weakness

If you are wondering whether 3M’s current share price lines up with its underlying worth, it helps to step back and look at the full valuation picture first. 3M closed at US$145.78, with returns of 9.1% over 1 year, 6.6% over 5 years, and shorter term moves of a 3.6% decline over 7 days, a 0.5% decline over 30 days, and a 9.9% decline year to date that may have shifted how the market is thinking about risk and opportunity. Recent coverage has focused on how investors are reassessing long...
NYSE:KBR
NYSE:KBRProfessional Services

Is It Time To Reassess KBR (KBR) After Recent Contract Wins And Share Price Slide?

Wondering whether KBR at around US$36 still reflects its true worth, or if the recent share price is sending a different signal about value? The stock has seen a 1.9% decline over the past week, a 4.9% decline over the last month, and is down 11.1% year to date and 29.4% over the past year, which may change how you think about both risk and opportunity. Over the last few months, headlines around KBR have focused on its role as a professional services provider, including contract wins and...
NYSE:FNB
NYSE:FNBBanks

F.N.B. Corporation Deal With Penn State Shifts Growth And Risk Profile

F.N.B. Corporation (NYSE:FNB) has entered an exclusive banking partnership with Penn State, covering all university campuses. The agreement makes F.N.B. the primary banking partner for the Penn State community, expanding its presence across the university system. F.N.B. has also appointed a new Chief Commercial Banking Officer to focus on corporate and institutional client relationships. For investors watching regional financial institutions, F.N.B. Corporation sits at the intersection of...
NYSE:DTM
NYSE:DTMOil and Gas

Assessing DT Midstream (DTM) Valuation After Mixed Short Term Moves And Strong Long Term Returns

Event context and recent share performance DT Midstream (DTM) has recently drawn attention after a period of mixed share performance, with a small gain over the past day, a modest decline over the past week, and a larger pullback over the past month. Over the past 3 months, the stock shows a positive total return. Over the past year and the past 3 years, total returns are higher again, which may prompt investors to reassess the current pricing of the business. See our latest analysis for DT...
NasdaqGS:TRIP
NasdaqGS:TRIPInteractive Media and Services

Tripadvisor And Starboard Agreement Puts Spotlight On Sale And TheFork Options

Tripadvisor (NasdaqGS:TRIP) has entered a cooperation agreement with activist investor Starboard Value. The deal gives Starboard immediate and upcoming representation on Tripadvisor’s board of directors. The board plans to review options for a potential sale of the company and for Tripadvisor’s restaurant booking unit, TheFork. For you as an investor, this puts fresh attention on Tripadvisor’s core role as a travel reviews and booking platform and on TheFork as a separate, restaurant...
NasdaqGS:TRS
NasdaqGS:TRSPackaging

Is It Too Late To Consider TriMas (TRS) After A 73% One Year Rally?

If you are wondering whether TriMas is still attractively priced after a strong run, this breakdown will help you see how the current share price lines up with several valuation checks. The stock closed at US$36.18, with returns of 2.5% over 30 days, a 0.3% decline year to date, and 73.2% over the last year, which has put the question of value and risk front and center for many investors. Recent coverage around TriMas has focused on its position in the packaging and materials space and how...
NYSE:DGX
NYSE:DGXHealthcare

Is Quest Diagnostics (DGX) Price Justified After Strong Multi‑Year Share Performance?

If you are wondering whether Quest Diagnostics at around US$204 is offering solid value or asking too much, you are in the right place for a closer look at what that price actually reflects. The stock has recorded returns of 6.6% over the last 7 days, 4.3% over 30 days, 17.4% year to date, 19.7% over 1 year, 47.5% over 3 years and 70.8% over 5 years. Recent price action is therefore an important part of the valuation story. Recent news coverage has focused on Quest Diagnostics as a key...
NYSE:GRMN
NYSE:GRMNConsumer Durables

Is It Too Late To Consider Garmin (GRMN) After Its Strong Multi Year Share Price Run?

Wondering if Garmin's share price still offers value after a strong run, or if most of the upside is already priced in? This article focuses squarely on what you are getting for the price you pay. Garmin recently closed at US$266.59, with returns of 0.3% over 7 days, 11.7% over 30 days, 31.7% year to date, 39.8% over 1 year, 196.4% over 3 years and 116.1% over 5 years, which puts the current valuation front and center for anyone considering the stock today. Recent coverage around Garmin has...
NYSE:CMP
NYSE:CMPMetals and Mining

Is It Too Late To Consider Compass Minerals International (CMP) After 126% One Year Surge?

Before getting into the details, start by asking a simple question: at around US$26.95 per share, does Compass Minerals International look attractively priced, or is the recent enthusiasm already reflected in the stock? Recent returns have been strong, with the share price showing gains of 8.6% over the last 7 days, 18.2% over 30 days, 35.7% year to date, and 125.7% over the past year, even though the 3 year and 5 year returns sit at 13.1% and 58.6% declines respectively. This combination of...
NasdaqGM:HRMY
NasdaqGM:HRMYPharmaceuticals

Is It Time To Revisit Harmony Biosciences Holdings (HRMY) After Its Recent Share Price Rebound?

If you are wondering whether Harmony Biosciences Holdings is priced attractively today, the key question is whether the current share price reflects its underlying fundamentals or if the market is mispricing the stock. The share price last closed at US$31.97, with recent returns of 9.4% over 7 days, 15.8% over 30 days, 10.6% over 1 year and a negative 14.5% return year to date. This may signal changing views on both potential and risk. Recent company specific news has kept Harmony...
NasdaqGS:TEM
NasdaqGS:TEMLife Sciences

Tempus AI USC Partnership Links Molecular Data To Hospital Usage And Valuation

Tempus AI (NasdaqGS:TEM) announced a new partnership with the Keck School of Medicine of USC and Keck Medicine of USC. The agreement covers integration of Tempus molecular diagnostics across a major Southern California healthcare network. The collaboration includes automation of clinical trial matching and AI driven support for care gap closure. The partners plan joint research and diagnostic co development tied to more than 1.5 million annual patient visits. For readers tracking healthcare...
NYSE:AIG
NYSE:AIGInsurance

Is It Time To Reconsider AIG (AIG) After Mixed Returns And Conflicting Valuations?

If you are looking at American International Group and wondering whether the current share price represents value, the key question is how that price compares with what the business might reasonably be worth. The stock last closed at US$76.03, with recent returns of a 1.4% decline over 7 days, a 1.3% gain over 30 days, a 9.8% decline year to date and a 4.8% decline over the past year, set against a 59.8% gain over 3 years and a 76.6% gain over 5 years. These mixed returns sit against a...